Ernexa Therapeutics Inc. (ERNA) earnings
Quarterly results of Ernexa Therapeutics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Ernexa Therapeutics Inc. was expected to report around November 6, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Ernexa Therapeutics Inc. reported revenue of - and a net loss of $4M.
Diluted earnings per share were -$3.40.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$4M | -$3.40 |
| Q1 FY2026 | - | - | -$5.5M | -$6.95 |
| Q4 FY2025 | - | - | -$1.5M | - |
| Q3 FY2025 | - | - | -$1.2M | -$0.15 |
| Q2 FY2025 | - | - | -$3.1M | -$15.19 |
| Q1 FY2025 | - | - | -$8.2M | -$57.76 |
| Q4 FY2024 | $1K | - | -$5.8M | - |
| Q3 FY2024 | $487K | - | -$26.6M | -$73.70 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
When is Ernexa Therapeutics Inc.'s next earnings date?
Ernexa Therapeutics Inc. was expected to report around November 6, 2026; nothing is on file with the SEC yet.
Get an email when ERNA reports
Follow ERNA and we email you its next results the day they are filed, with the numbers explained.